Awan, Tashfeen
(Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab)
Iqbal, Zafar (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Aleem, Aamer (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Sabir, Noreen (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Absar, Muhammad (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Rasool, Mahmood (Centre of Excellence in Genomic Medicine Research, King Abdulaziz University) Tahir, Ammara H. (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Basit, Sulman (Biochemistry Research Section, Department of Anatomy, College of Medicine and King Khalid University Hospital, King Saud University) Khalid, Ahmad Mukhtar (School of Biological Sciences, University of Sargodha) Sabar, Muhammad Farooq (Centre for Advanced Molecular Biology & National Centre of Excellence in Molecular Biology) Asad, Sultan (Centre for Advanced Molecular Biology & National Centre of Excellence in Molecular Biology) Ali, Agha Shabbir (Post Graduate Medical Institute & Institute of Child Health) Mahmood, Amer (Embryonic Stem Cell Unit, Department of Anatomy, College of Medicine and King Khalid University Hospital, King Saud University) Akram, Muhammad (Department of Oncology, Allama Iqbal Medical College and Jinnah Hospital) Saeed, Tariq (Department of Oncology, Allama Iqbal Medical College and Jinnah Hospital) Saleem, Arsalan (University of Health Sciences) Mohsin, Danish (University of Health Sciences) Shah, Ijaz Hussain (Department of Oncology, Punjab Medical College and Allied Hospital) Khalid, Muhammad (Department of Oncology, Punjab Medical College and Allied Hospital) Asif, Muhammad (Department of Biotechnology and Informatics, (BUITEMS)) Haq, Riazul (Health Centre, University of Texas San Antonio) Iqbal, Mudassar (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) Akhtar, Tanveer (Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences Laboratories, Faculty of Biological Sciences, Department of Zoology, University of the Punjab) |
1 | Andersen MK, Autio K, Barbany G, et al (2011). Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19) (q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. Br J Haematol, 155, 235-43. DOI |
2 | Ariffin H, Chen SP, Kwok CS, et al (2007). Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: results of the Malaysia-Singapore Leukemia Study Group. J Pediatr Hematol Oncol, 29, 27-31. DOI |
3 | Ashraf MS (2012) Pediatric Oncology in Pakistan. J Pediatr Hematol Oncol, 34, 23-5. DOI |
4 | Bhojwani D, Pei D, Sandlund JT, et al (2012). ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia, 26, 265-70. DOI |
5 | Bowman WP, Larsen EL, Devidas M, et al (2011). Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer, 57, 569-77. DOI |
6 | Burmeister T, Nicola G, Stefan S, et al (2010). Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia. Haematologic, 5, 241-6. |
7 | Cheok MH, Evans WE (2006). Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer Therapy. Nat Rev Cancer, 6, 117-29. DOI |
8 | DeBraekeleer E, Basinko A, Douet-Guilbert N, et al (2010). Cytogenetics in pre-B and B-cell acute lymphoblastic leukemia: a study of 208 patients diagnosed between 1981 and 2008. Cancer Genetics and Cytogenetics, 200, 8-15. DOI |
9 | El-Sissy A, El-Mashari M, Bassuni W, et al (2006). A molecular detection of BCR/ABL fusion gene in Saudi acute lymphoblastic leukemia patients. J Egypt Natl Canc Inst, 18, 109-16. |
10 | Faiz M, Qureshi AM, Qazi JI (2011). Molecular characterization of different fusion oncogenes associated with childhood Acute Lymphoblastic leukaemia from Pakistan. IJAVMS, 5, 497-507. DOI |
11 | Gaynon PS, Crotty ML, Sather HN, et al (1997). Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative. Leuk Lymphoma, 26, 57-65. DOI |
12 | Iqbal Z, Iqbal M, Akhter T (2007). Frequency of BCR-ABL fusion oncogene in Pakistani childhood acute lymphoid leukemia (ALL) patients reflects ethnic differences in molecular genetics of ALL. J Pediatr Hematol Oncol, 29, 585. DOI ScienceOn |
13 | Hunger SP, Lu X, Devidas M, et al (2012). Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol, 30, 1663-9. DOI |
14 | Iacobucci I, Papayannidis C, Lonetti A, et al (2012). Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments. Curr Hematol Malig Rep, 7, 133-43. DOI ScienceOn |
15 | Iqbal Z, Tanveer A (2006). Incidence of different fusion oncogenes in acute Lymphoblastic Leukemia (ALL) patients from Pakistan: possible implications in differential diagnosis, prognosis, treatment and management of ALL. Haematologica, 91, 64. |
16 | Iqbal Z, Awan T, Iqbal M, et al (2012). High frequency of BCRABL oncogene in pediatric acute lymphoblastic leukemia (ALL) patients as revealed by RT-PCR and interphase FISH: association with disease biology and treatment outcome. J Clin Oncol, 30, 444. |
17 | Jimenez-Morales S, Miranda-Peralta E, Saldana-Alvarez Y, et al (2008). BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients. Leuk Res, 32, 1518-22. DOI |
18 | Kuiper RP, Schoenmakers EF, van Reijmersdal SV, et al (2007). High resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia, 21, 1258-66. DOI ScienceOn |
19 | Leung W, Campana D, Yang J, et al (2011). High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood, 118, 223-30. DOI |
20 | Lazic J, Tosic N, Dokmanovic L, et al (2010). Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia. Med Oncol, 27, 449-53. DOI ScienceOn |
21 | McGregor S, McNeer J, Gurbuxani S (2012). Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol, 29, 2-11. DOI |
22 | Mesquita DR, Cordoba JC, Magalhaes IQ, et al (2009). Molecular and chromosomal mutations among children with B-lineage lymphoblastic leukemia in Brazil's federal district. Genet Mol Res, 8, 345-53. DOI |
23 | Pui CH, Carroll WL, Meshinchi S, et al (2011). Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol, 29, 551-65. DOI ScienceOn |
24 | Pui CH, Robison LL, Look AT (2008). Acute Lymphoblastic Leukaemia. Lancet, 371, 1030-43. DOI |
25 | Pui CH, Sandlund JT, Pei D, et al (2004). Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood, 104, 2690-6. DOI |
26 | Pui CH, Sandlund JT, Pei D, et al (2003). Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA, 290, 2001-7. DOI |
27 | Pulsipher MA, Peters C, Pui CH (2011). High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant? Biol Blood Marrow Transplant, 17, 137-48. DOI |
28 | Rives S, Estella J, Gomez P, et al (2011). Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. Br J Haematol, 154, 600-11. DOI |
29 | Raimondi SC, Pui CH, Hancock ML, et al (1996). Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia, 10, 213-24. |
30 | Reichard KK, Kang H, Robinett S (2011). Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases. Mod Pathol, 24, 1606-11. DOI |
31 | Romana SP, Poirel H, Leconiat M, et al (1995). High frequency of t(12; 21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-9. |
32 | Sabir N, Iqbal Z, Aleem A, et al (2012). Prognostically Significant Fusion Oncogenes in Pakistani Patients with Adult Acute Lymphoblastic Leukemia and their Association with Disease Biology and Outcome. Asian Pac J Cancer Prev, 13, 3349-55. DOI ScienceOn |
33 | Schmiegelow K, Lausten TU, Baruchel A, et al (2012). High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia. Leukemia, 26, 675-81. DOI |
34 | Schultz KR, Bowman WP, Aledo A, et al (2009). Improved early EFS with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. J Clin Oncol, 27, 5175-81. DOI |
35 | Siddiqui R, Nancy N, Naing WP, et al (2010). Distribution of common genetic subgroups in childhood acute lymphoblasticleukemia in four developing countries. Cancer Genet Cytogenet, 200, 149-53. DOI |
36 | Xu H, Cheng C, Devidas M, et al (2012). ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol, 30, 751-7. DOI |
37 | Siraj AK, Ozbek U, Sazawal S, et al (2002). Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia. Clin Cancer Res, 8, 3832-40. |
38 | Trevino LR, Yang W, French D, et al (2009). Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet, 41, 1001-5. DOI |
39 | van Dongen JJ, Macintyre EA, Gabert JA, et al (1999). Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 1901-28. DOI |
40 | Zhang J, Mullighan CG, Harvey RC, et al (2011). Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood, 118, 3080-7. DOI |